Published: Apr 26, 2024 By Tristan Manalac
Pictured: Cigna Group signage outside its office in Connecticut/iStock, JHVEPhoto
Cigna subsidiary Evernorth Health Services announced on Thursday that it will offer a Humira (adalimumab) biosimilar with no out-of-pocket cost…
Click here to view original post
Click Here to Publish/Feature Your Company or Product News with Biotech Networks
